GO:0005540 hyaluronic acid binding: Mechanism, Genes

Hyaluronic acid binding (GO:0005540) is the molecular function of selectively and non-covalently interacting with hyaluronic acid, a high-molecular-weight glycosaminoglycan composed of repeating dimeric units of glucuronic acid and N-acetyl glucosamine. This function is central to how cells sense and respond to the extracellular matrix, and it is mediated by a defined set of receptors and hyaluronic acid-binding proteins. The best-known receptor is CD44, whose binding activity is dynamically regulated by receptor clustering, post-translational modification and cytoskeletal interactions. Another key receptor is TLR4, which can bind hyaluronic acid and thereby promote proliferation and block apoptosis in colon cancer cells. Because hyaluronic acid is abundant in connective tissues, synovial fluid and many tumors, proteins that carry this function are studied across reproductive biology, oncology, immunology and regenerative medicine. For researchers, GO:0005540 provides a precise annotation axis to distinguish true hyaluronic acid receptors from other matrix-binding proteins. The function is experimentally tractable: sperm hyaluronic acid binding is a validated marker of cellular maturity and fertilizing potential and is used to select sperm for intracytoplasmic sperm injection, and clinical benefit of sperm hyaluronic acid binding selection in ICSI cycles has been evaluated in systematic review and meta-analysis. In parallel, engineered hyaluronic acid-binding peptides are being developed as therapeutic tools for osteoarthritis, and binding specificity can be measured with carbohydrate-binding-module-based lateral flow assays. Mechanistically, hyaluronic acid binding is not a single binary event. CD44S binds hyaluronic acid indiscriminately of molecular weight, indicating that receptor state rather than ligand size can dominate recognition. This has practical implications for assay design and for interpreting whether a candidate protein is a bona fide hyaluronic acid-binding protein. The sections below summarize the definition, core biology, key genes, disease links, model systems and methods used to study GO:0005540.

In your own words, GO:0005540 hyaluronic acid binding is the molecular function of binding to hyaluronic acid, a polymer built from repeating dimeric units of glucuronic acid and N-acetyl glucosamine. It is a binding function, not a catalytic activity: the annotated protein physically interacts with hyaluronic acid without necessarily modifying it. The synonym hyaluronan binding is equivalent. This function is typically measured by solid-phase binding assays, flow cytometry, surface plasmon resonance or functional cell adhesion assays, and it underlies processes such as matrix sensing, immune signaling, sperm selection and tissue hydration.

GO:0005540 matters because hyaluronic acid is a ubiquitous extracellular matrix glycosaminoglycan, and the proteins that bind it translate matrix composition into cell behavior. CD44 binding to hyaluronic acid is regulated at the level of receptor activity and clustering, and TLR4 binding to hyaluronic acid can drive proliferation and suppress apoptosis in colon cancer. In reproductive medicine, sperm hyaluronic acid binding is a functional biomarker of maturity and fertilizing potential used for ICSI selection, with meta-analytic evidence of clinical benefit. In translational bioengineering, hyaluronic acid-binding peptides are being engineered for osteoarthritis therapy, and binding detection is being adapted into point-of-care formats. Thus, this GO term connects basic matrix biology to cancer, inflammation, fertility and therapeutic design.

The following genes and proteins represent major experimental entry points for studying GO:0005540 hyaluronic acid binding.

Hyaluronic acid binding is regulated at the level of receptor activity and availability. CD44 binding to hyaluronic acid is controlled by mechanisms including receptor clustering and cytoskeletal association, as reviewed by Liu et al.. This means that signaling inputs that alter the actin cytoskeleton or receptor distribution can change hyaluronic acid-binding capacity without changing ligand concentration. In addition, the identity of the receptor determines the downstream response: TLR4 binding to hyaluronic acid promotes proliferation and blocks apoptosis in colon cancer cells, whereas CD44S binds hyaluronic acid indiscriminately of molecular weight. Ligand availability is also regulated by hyaluronic acid synthases and hyaluronidases, which produce and degrade the polymer, respectively. Together, these layers of regulation determine when and where GO:0005540 is functionally engaged.

Hyaluronic acid binding to TLR4 promotes proliferation and blocks apoptosis in colon cancer, directly linking GO:0005540 to tumor cell survival. CD44, the principal hyaluronic acid receptor, has binding activity regulated by receptor clustering and cytoskeletal association, and altered CD44-dependent hyaluronic acid binding is a recurring theme in matrix-rich tumors. Because CD44S binds hyaluronic acid indiscriminately of molecular weight, both fragmented and high-molecular-weight hyaluronic acid can engage the receptor in the tumor microenvironment, potentially sustaining proliferative signaling.

The hyaluronic acid binding ability of human sperm reflects cellular maturity and fertilizing potential, and this property is used to select sperm for intracytoplasmic sperm injection. Clinical benefit of the sperm hyaluronic acid binding technique in ICSI cycles has been evaluated in a systematic review and meta-analysis. A hyaluronic acid-containing reagent compatible with glass-bottom dishes has also been developed to sustain binding of human spermatozoa, supporting functional studies and imaging of this molecular function in reproductive biology.

A hyaluronic acid binding peptide-polymer system has been developed for treating osteoarthritis, demonstrating that engineered hyaluronic acid-binding modules can be used therapeutically to target and retain material in joint tissues. This application depends on the same molecular function annotated as GO:0005540 and illustrates how understanding hyaluronic acid recognition can be translated into disease-modifying strategies.

A carbohydrate binding module-based lateral flow immunoassay method has been established for identifying hyaluronic acid. This diagnostic application relies on the specificity of hyaluronic acid-binding modules and shows that GO:0005540 has practical utility beyond cell biology, including point-of-care detection of hyaluronic acid in clinical and research samples.

Hyaluronic acid binding can be measured using solid-phase binding assays and lateral flow formats. A carbohydrate binding module-based lateral flow immunoassay method has been established for identifying hyaluronic acid, providing a rapid and specific readout. These methods are useful for validating whether a candidate protein carries GO:0005540 and for quantifying binding under different ligand conditions.

Because CD44 binding to hyaluronic acid is regulated by receptor clustering and cytoskeletal association, functional assays should capture receptor distribution and adhesion. Cell adhesion to hyaluronic acid-coated surfaces, combined with imaging of receptor clustering, can distinguish changes in binding activity from changes in receptor abundance. Such assays are essential for testing regulatory mechanisms.

The hyaluronic acid binding ability of human sperm reflects cellular maturity and fertilizing potential and is used to select sperm for intracytoplasmic sperm injection. Clinical benefit of the sperm hyaluronic acid binding technique in ICSI cycles has been assessed by systematic review and meta-analysis. A hyaluronic acid-containing reagent compatible with glass-bottom dishes sustains binding of human spermatozoa, enabling live imaging and controlled binding experiments.

To study the functional consequences of hyaluronic acid binding in cancer, proliferation and apoptosis assays can be combined with receptor perturbation. Hyaluronic acid binding to TLR4 promotes proliferation and blocks apoptosis in colon cancer, so TLR4 knockout or point-mutation models coupled with proliferation and apoptosis readouts provide a direct test of this axis. CD44S binding to hyaluronic acid is indiscriminate of molecular weight, which should be considered when designing ligand treatments.

Researchers studying hyaluronic acid binding-related genes often need to determine whether a candidate gene is causally involved in ligand recognition, receptor clustering or downstream signaling. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible testing of GO:0005540-related hypotheses.

GO:0005540 hyaluronic acid binding defines a molecular function with broad biological and clinical reach. CD44 and TLR4 are the best-characterized receptors, with CD44 binding regulated by clustering and cytoskeletal association and TLR4 binding driving proliferation and apoptosis blockade in colon cancer. CD44S binds hyaluronic acid indiscriminately of molecular weight, and engineered hyaluronic acid-binding peptides are being developed for osteoarthritis. In reproductive medicine, sperm hyaluronic acid binding is a validated functional marker used for ICSI selection [1,2], and detection methods such as lateral flow assays and glass-compatible reagents continue to expand the toolkit. For researchers, the next step is causal testing. CRISPR knockout, point-mutation, knock-in and overexpression models allow precise interrogation of hyaluronic acid-binding proteins in cancer, inflammation, fertility and matrix disease. EDITGENE provides these services to accelerate hypothesis-driven studies of GO:0005540.